Transactivation of PDGFR by dopamine D4 receptor does not require PDGFR dimerization

Molecular Brain

Volumn 3, Issue 1, 2010, Pages

  Chi, Sum Shing ^a   Vetiska, Sandra M ^a   Gill, Robin S ^a   Hsiung, Marilyn S ^a   Liu, Fang ^a   Van Tol, Hubert Hm ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE 4 RECEPTOR; G PROTEIN COUPLED RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROTEIN TYROSINE KINASE; DOPAMINE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOTYROSINE; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR BB; PLATELET-DERIVED GROWTH FACTOR BB; SMALL INTERFERING RNA;

ANIMAL TISSUE; ARTICLE; AUTOCRINE EFFECT; CONTROLLED STUDY; DIMERIZATION; MOUSE; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TRANSACTIVATION; ANIMAL; CELL LINE; DRUG EFFECT; ENZYME ACTIVATION; GENETICS; HUMAN; METABOLISM; PHOSPHORYLATION; PROTEIN MULTIMERIZATION; TRANSCRIPTION INITIATION;

ANIMALS; CELL LINE; DOPAMINE; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; MICE; PARACRINE COMMUNICATION; PHOSPHORYLATION; PHOSPHOTYROSINE; PLATELET-DERIVED GROWTH FACTOR; PROTEIN MULTIMERIZATION; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; RECEPTORS, DOPAMINE D4; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSCRIPTIONAL ACTIVATION;

EID: 77954870422     PISSN: None     EISSN: 17566606     Source Type: Journal    
DOI: 10.1186/1756-6606-3-22     Document Type: Article

References (34)

1. Signal transduction via platelet-derived growth factor receptors. CH Heldin A Ostman L Ronnstrand, Biochim Biophys Acta 1998 1378 79 113 9739761
2. G-protein-coupled receptors and signaling networks: emerging paradigms. MJ Marinissen JS Gutkind, Trends Pharmacol Sci 2001 22 368 376 10.1016/S0165-6147(00)01678-3 11431032
3. Ras activation in response to lysophosphatidic acid requires a permissive input from the epidermal growth factor receptor. I Rubio K Rennert U Wittig R Wetzker, Biochem J 2003 376 571 576 10.1042/BJ20031410 14580235
4. Signal transduction of angiotensin II type 1 receptor through receptor tyrosine kinase. S Eguchi T Inagami, Regul Pept 2000 91 13 20 10.1016/S0167-0115(00)00126-9 10967198
5. Agonist-specific transactivation of phosphoinositide 3-kinase signaling pathway mediated by the dopamine D2 receptor. VD Nair SC Sealfon, J Biol Chem 2003 278 47053 47061 10.1074/jbc.M303364200 12970364
6. Dopamine D(4) and D(2L) Receptor Stimulation of the Mitogen-Activated Protein Kinase Pathway Is Dependent on trans-Activation of the Platelet-Derived Growth Factor Receptor. JN Oak N Lavine HH Van Tol, Mol Pharmacol 2001 60 92 103 11408604
7. Distinct regulation of internalization and mitogen-activated protein kinase activation by two isoforms of the dopamine D2 receptor. SJ Kim MY Kim EJ Lee YS Ahn JH Baik, Mol Endocrinol 2004 18 640 652 10.1210/me.2003-0066 14684845
8. Dopamine D2 receptor stimulation of mitogen-activated protein kinases mediated by cell type-dependent transactivation of receptor tyrosine kinases. C Wang DC Buck R Yang TA Macey KA Neve, J Neurochem 2005 93 899 909 10.1111/j.1471-4159.2005.03055.x 15857393
9. The beta(2)-adrenergic receptor mediates extracellular signal-regulated kinase activation via assembly of a multi-receptor complex with the epidermal growth factor receptor. S Maudsley KL Pierce AM Zamah WE Miller S Ahn Y Daaka RJ Lefkowitz LM Luttrell, J Biol Chem 2000 275 9572 9580 10.1074/jbc.275.13.9572 10734107
10. The m1 muscarinic acetylcholine receptor transactivates the EGF receptor to modulate ion channel activity. W Tsai AD Morielli EG Peralta, EMBO J 1997 16 4597 4605 10.1093/emboj/16.15.4597 9303304
11. Angiotensin II type 1 receptor-induced extracellular signal-regulated protein kinase activation is mediated by Ca2+/calmodulin-dependent transactivation of epidermal growth factor receptor. S Murasawa Y Mori Y Nozawa N Gotoh M Shibuya H Masaki K Maruyama Y Tsutsumi Y Moriguchi Y Shibazaki, et al. Circ Res 1998 82 1338 1348 9648731
12. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. N Prenzel E Zwick H Daub M Leserer R Abraham C Wallasch A Ullrich, Nature 1999 402 884 888 10622253
13. A D2 class dopamine receptor transactivates a receptor tyrosine kinase to inhibit NMDA receptor transmission. SA Kotecha JN Oak MF Jackson Y Perez BA Orser HH Van Tol JF MacDonald, Neuron 2002 35 1111 1122 10.1016/S0896-6273(02) 00859-0 12354400
14. Phosphorylation of the platelet-derived growth factor receptor-beta and epidermal growth factor receptor by G protein-coupled receptor kinase-2. Mechanisms for selectivity of desensitization. NJ Freedman LK Kim JP Murray ST Exum L Brian JH Wu K Peppel, J Biol Chem 2002 277 48261 48269 10.1074/jbc.M204431200 12381737
15. Inhibition of PDGF beta receptor signal transduction by coexpression of a truncated receptor. H Ueno H Colbert JA Escobedo LT Williams, Science 1991 252 844 848 10.1126/science.1851331 1851331
16. Cloning and expression of a cDNA coding for the human platelet-derived growth factor receptor: evidence for more than one receptor class. RG Gronwald FJ Grant BA Haldeman CE Hart PJ O'Hara FS Hagen R Ross DF Bowen-Pope MJ Murray, Proc Natl Acad Sci USA 1988 85 3435 3439 10.1073/pnas.85.10.3435 2835772
17. Functional importance of platelet-derived growth factor (PDGF) receptor extracellular immunoglobulin-like domains. Identification of PDGF binding site and neutralizing monoclonal antibodies. NA Lokker JP O'Hare A Barsoumian JE Tomlinson V Ramakrishnan LJ Fretto NA Giese, J Biol Chem 1997 272 33037 33044 10.1074/jbc.272.52.33037 9407086
18. Immunoglobulin-like domain 4-mediated receptor-receptor interactions contribute to platelet-derived growth factor-induced receptor dimerization. T Omura CH Heldin A Ostman, J Biol Chem 1997 272 12676 12682 10.1074/jbc.272.19. 12676 9139724
19. Use of vanadate as protein-phosphotyrosine phosphatase inhibitor. JA Gordon, Methods Enzymol 1991 201 477 482 full-text 1943774
20. Rapid high resolution western blotting: from gel to image in a single day. A Klapper B MacKay MD Resh, Biotechniques 1992 12 650 654 1515130
21. Full activation of the platelet-derived growth factor beta-receptor kinase involves multiple events. RM Baxter JP Secrist RR Vaillancourt A Kazlauskas, J Biol Chem 1998 273 17050 17055 10.1074/jbc.273.27.17050 9642269
22. Synthesis, phosphorylation, and degradation of multiple forms of the platelet-derived growth factor receptor studied using a monoclonal antibody. CE Hart RA Seifert R Ross DF Bowen-Pope, J Biol Chem 1987 262 10780 10785 2440874
23. Processing of the platelet-derived growth factor receptor. Biosynthetic and degradation studies using anti-receptor antibodies. MT Keating LT Williams, J Biol Chem 1987 262 7932 7937 3034910
24. "Ins and outs" of seven-transmembrane receptor signalling to ERK. TD Werry PM Sexton A Christopoulos, Trends Endocrinol Metab 2005 16 26 33 10.1016/j.tem.2004.11.008 15620546
25. Platelet-derived growth factor C (PDGF-C), a novel growth factor that binds to PDGF alpha and beta receptor. DG Gilbertson ME Duff JW West JD Kelly PO Sheppard PD Hofstrand Z Gao K Shoemaker TR Bukowski M Moore, et al. J Biol Chem 2001 276 27406 27414 10.1074/jbc.M101056200 11297552
26. Epidermal growth factor (EGF) receptor-dependent ERK activation by G protein-coupled receptors: a co-culture system for identifying intermediates upstream and downstream of heparin-binding EGF shedding. KL Pierce A Tohgo S Ahn ME Field LM Luttrell RJ Lefkowitz, J Biol Chem 2001 276 23155 23160 10.1074/jbc.M101303200 11290747
27. Chimeric alpha- and beta-platelet-derived growth factor (PDGF) receptors define three immunoglobulin-like domains of the alpha-PDGF receptor that determine PDGF-AA binding specificity. MA Heidaran JH Pierce RA Jensen T Matsui SA Aaronson, J Biol Chem 1990 265 18741 18744 2172231
28. Structural coincidence of alpha PDGFR epitopes binding to platelet-derived growth factor-AA and a potent neutralizing monoclonal antibody. JC Yu D Mahadevan WJ LaRochelle JH Pierce MA Heidaran, J Biol Chem 1994 269 10668 10674 7511602
29. Autoinhibition of the platelet-derived growth factor beta-receptor tyrosine kinase by its C-terminal tail. F Chiara S Bishayee CH Heldin JB Demoulin, J Biol Chem 2004 279 19732 19738 10.1074/jbc.M314070200 14996833
30. Ligand activation causes a phosphorylation-dependent change in platelet-derived growth factor receptor conformation. MT Keating JA Escobedo LT Williams, J Biol Chem 1988 263 12805 12808 2843499
31. A comparison of the platelet-derived growth factor-dependent tyrosine kinase activity in sparse and confluent fibroblasts. A Kazlauskas PE DiCorleto, J Cell Physiol 1986 126 225 236 10.1002/jcp.1041260211 3003124
32. Dissociation of platelet-derived growth factor (PDGF) receptor autophosphorylation from other PDGF-mediated second messenger events. MA Quinones LJ Mundschau JB Rake DV Faller, J Biol Chem 1991 266 14055 14063 1713214
33. PDGF-BB-mediated activation of p42(MAPK) is independent of PDGF beta-receptor tyrosine phosphorylation. NJ Cartel J Liu J Wang M Post, Am J Physiol Lung Cell Mol Physiol 2001 281 786 L798 11557582
34. The dopamine D4 receptor activates intracellular platelet-derived growth factor receptor beta to stimulate ERK1/2. RS Gill MS Hsiung CS Sum N Lavine SD Clark HH Van Tol, Cell Signal 2010 22 285 290 10.1016/j.cellsig.2009.09.031 19782129